VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > what the

<< Previous

Bullboard Posts

Next >>

Post by shawshank666on Nov 29, 2023 10:50pm

187 Views

Post# 35760201

what the

I was expecting at least the 2 sales to the Germans to be on the books by the end of the third quarter but they didn't even show 2 sales, they showed one sale. If the revenue from the sale of one VMS unit is $50,000 US then that is about $70,000 CDN which is what they posted as the sales for the 3 quarters. And what about all those sales they were supposed to happen in the third and fourth quarters as they talked about in the spring. Are they going to happen in the fourth quarter? I hope I can get some answers out of Alvira on Friday.

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario